Two distinct signaling pathways for regulation of spontaneous local Ca2+ release by phospholipase C in airway smooth muscle cells

Pflugers Arch. 2007 Jan;453(4):531-41. doi: 10.1007/s00424-006-0130-1. Epub 2006 Nov 9.

Abstract

Spontaneous local Ca(2+) release events have been observed in airway smooth muscle cells (SMCs), but the underlying mechanisms are largely unknown. Considering that each type of SMCs may use its own mechanisms to regulate local Ca(2+) release events, we sought to investigate the signaling pathway for spontaneous local Ca(2+) release events in freshly isolated mouse airway SMCs using a laser scanning confocal microscope. Application of ryanodine to block ryanodine receptors (RyRs) abolished spontaneous local Ca(2+) release events, indicating that these events are RyR-mediated Ca(2+) sparks. Inhibition of inositol 1,4,5-triphosphate receptors (IP(3)Rs) by 2-aminoethoxydiphenyl-borate (2-APB) or xestospongin-C significantly blocked the activity of Ca(2+) sparks. Under patch clamp conditions, dialysis of IP(3) to activate IP(3)Rs increased the activity of local Ca(2+) events in control cells but had no effect in ryanodine-pretreated cells. The RyR agonist caffeine augmented the frequency of Ca(2+) sparks in cells pretreated with and without 2-APB or xestospongin-C. The specific phospholipase C (PLC) blocker U73122 decreased the activity of Ca(2+) sparks and prevented xestospongin-C from producing the inhibitory effect. The protein kinase C (PKC) activator 1-oleoyl-2-acetyl-glycerol or phorbol-12-myristate-13-acetate inhibited Ca(2+) sparks, whereas the PKC inhibitor chelerythrine, PKCvarepsilon inhibitory peptide, or PKCvarepsilon gene knockout produced an opposite effect. Collectively, our data suggest that the basal activation of PLC regulates the activity of RyR-mediated, spontaneous Ca(2+) sparks in airway SMCs through two distinct signaling pathways: a positive IP(3)-IP(3)R pathway and a negative diacylglycerol-PKCvarepsilon pathway.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology
  • Animals
  • Benzophenanthridines / pharmacology
  • Boron Compounds / pharmacology
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Cells, Cultured
  • Diglycerides / pharmacology
  • Estrenes / pharmacology
  • Inositol 1,4,5-Trisphosphate / metabolism
  • Inositol 1,4,5-Trisphosphate Receptors / antagonists & inhibitors
  • Inositol 1,4,5-Trisphosphate Receptors / physiology
  • Macrocyclic Compounds / pharmacology
  • Male
  • Mice
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism*
  • Oxazoles / pharmacology
  • Pyrrolidinones / pharmacology
  • Respiratory System / cytology
  • Respiratory System / drug effects
  • Respiratory System / metabolism
  • Ryanodine / pharmacology
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Ryanodine Receptor Calcium Release Channel / physiology
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism*

Substances

  • Alkaloids
  • Benzophenanthridines
  • Boron Compounds
  • Diglycerides
  • Estrenes
  • Inositol 1,4,5-Trisphosphate Receptors
  • Macrocyclic Compounds
  • Oxazoles
  • Pyrrolidinones
  • Ryanodine Receptor Calcium Release Channel
  • xestospongin C
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Ryanodine
  • Caffeine
  • Inositol 1,4,5-Trisphosphate
  • 1-oleoyl-2-acetylglycerol
  • chelerythrine
  • 2-aminoethoxydiphenyl borate
  • Type C Phospholipases
  • Calcium